Lippert, T. H., Ruoff, H., & Volm, M. (2014). Could a revision of the current guidelines for cancer drug use improve the quality of cancer treatment? Therapeutics and clinical risk management, 10, . https://doi.org/10.2147/TCRM.S51404
Chicago Style (17th ed.) CitationLippert, Theodor H., Hans-Jörg Ruoff, and Manfred Volm. "Could a Revision of the Current Guidelines for Cancer Drug Use Improve the Quality of Cancer Treatment?" Therapeutics and Clinical Risk Management 10 (2014). https://doi.org/10.2147/TCRM.S51404.
MLA (9th ed.) CitationLippert, Theodor H., et al. "Could a Revision of the Current Guidelines for Cancer Drug Use Improve the Quality of Cancer Treatment?" Therapeutics and Clinical Risk Management, vol. 10, 2014, https://doi.org/10.2147/TCRM.S51404.
Warning: These citations may not always be 100% accurate.